BradMD (Brad Hennenfent, M.D.) Physician & Economist (retired). The Treatment Score = the net treatment benefit for the patient and will improve patient care while solving health illiteracy.
The CDC, NIH, and other government agencies should never publish "Guidelines," they should only publish opinions, and Artificial Intelligence (AI) seems to agree with me: https://lnkd.in/eCfnQ-bc #health #medicine #digitalhealth #medtech #healthcareinnovation
New The Health Foundation blog published today with Talia Boshari: "What could 'personalised prevention' mean for our health?" ‘Personalised prevention’ isn't new, but the term is becoming increasingly widespread in political, clinical and public discourse in England as growth in technology, data collection and AI create more opportunities for personalisation in health care. This brief introduction unpicks what personalised prevention is and puts into context some the hype around what it could do for the NHS. And as ever, nothing beats dealing with the building blocks of health in the first place: things like good quality housing, a good education, and secure employment. #Digital #PersonalisedPrevention #Tech #AI #Health #PublicHealth #Prevention https://lnkd.in/dF8F_qkq
AI is making waves in clinical research, especially in how we tackle infectious diseases. From improving diagnostic accuracy to personalizing treatments, the impact is undeniable. It’s fascinating to see how these advancements are shaping a more efficient and precise future for patient care. Check out this recent article that dives into AI's role in transforming healthcare. Not enough time to read through the full article on AI transforming healthcare? No worries—I’ve got you covered! 🧠✨ I used AI to generate a concise summary, highlighting the key points you need to know. Check it out below: - AI improves diagnostics and personalized care. - It enhances outbreak detection and management. - Challenges include data privacy and potential biases. - Regulatory frameworks are essential for responsible AI use. What’s your take on AI in research? #ClinicalResearch #Innovation #MedicalDevices
CEO and Founder of Aspedan | Entrepreneur | Building a Universal Digital Health and Wellness Platform | Extending Healthy Lifespans For All and Pioneering Longevity
Generative AI is opening the door to endless opportunities in public health. It has the potential to revolutionise how we deliver healthcare, prepare for future health threats, and fast-track the creation of treatments for diseases that significantly impact public health. This technology could play a crucial role in improving the effectiveness of public health systems at the global, national, state, and local levels. As a result, it may significantly enhance the health and wellbeing of communities. 🏥🧑🏽⚕️ 🤖 https://lnkd.in/eg6MuVke
📢 New Blog: The Future of Long COVID Care Lies in Data Interoperability Long COVID has emerged as one of the most complex public health challenges of our time. With millions affected globally, understanding its long-term impact requires more than anecdotes—it demands actionable data. 📊 In our latest blog, we explore: ✅ The evolving research landscape on Long COVID ✅ How standardized data is being used to uncover patterns and inform better care ✅ What it means for individuals, healthcare systems, and policymakers At EMI Advisors, we believe in the power of data to drive solutions. This blog reflects our commitment to fostering innovation and improving whole-person care using data standards and data-driven insights. 👉 Read the full blog here: https://lnkd.in/gV2xbHgt #HealthcareInnovation #EMI #DataStandards #LongCOVID #AI #ML
"By allowing clinicians to be more efficient and to focus their time on what they do best, AI will help them be able to care for even more patients than they can today underneath all their administrative burdens." Dive deeper into the topic of AI in this post written by our CEO, Kyna Fong, PhD.
By allowing clinicians to be more efficient and to focus their time on what they do best, AI will help them be able to care for even more patients than they can today underneath all their administrative burdens. https://lnkd.in/eCUbEUw3 Written by Kyna Fong, PhD of Elation Health
Generative AI could lead to powerful new advancements in public health and healthcare. Check out McKinsey & Company's recent article and learn: 🤖 Potential GenAI use cases in four public health domains 🤔 Considerations for organisations adopting GenAI 🏥 Public health-specific risks to mitigate and manage 🚀 5 steps to get started with GenAI in public health Read the full article: https://lnkd.in/eSHjgu7E #GenAI #Healthcare
A new study demonstrates AI's potential to diagnose rare diseases years earlier than conventional methods. The AI program accurately identified individuals at risk of a rare immune disorder, with 74 out of 100 high-risk cases confirmed to likely have the disorder. Lead researcher Ruth Johnson highlights the detrimental effects of delayed diagnosis, including increased infections and hospitalizations. The AI, named PheNet, learns disease patterns from verified cases and ranks individuals' risk based on electronic health records. With promising results, the research team has secured funding to further develop and implement PheNet across medical centers, aiming to expedite diagnosis for CVID and potentially other rare diseases, enhancing patient care. Read the full article: https://lnkd.in/e_jUtJ5U #health #healthai #healthcare #ai #artificialintelligence #healthnews #ModerndoctorAI #AIinHealthcare #DigitalHealth #HealthcareInnovation #MedTech #HealthTech #AIHealthcare #HealthIT #HealthTechNews #AIandHealthcare
Have a look at #InnoRadarEU's page for the #EUfunded #innovation: 'Open AI Platform to allow healthcare providers offer their patients improved predictions and personalized support'. European Commission Deutsches Forschungszentrum für Künstliche Intelligenz (DFKI) #OpenAI #ArtificialIntelligence
China has unveiled the world’s first AI hospital, named “Agent Hospital,” capable of treating up to 3,000 patients a day. Developed by researchers at Tsinghua University in Beijing, this groundbreaking facility is expected to be operational by the second half of 2024, following six months of intensive research and development. Key Features: 1. High Patient Capacity: AI doctors can treat 3,000 patients daily. 2. Efficiency: AI doctors achieve in days what humans would take years to accomplish. 3. Advanced Training: Real doctors treat virtual patients in a risk-free environment. 4. High Accuracy: 93.06% accuracy rate on US Medical Licensing Exam questions. 5. Disease Simulation: Simulates medical scenarios, including infectious disease management. Thoughts on this? To never miss any AI update, subscribe to our free AI newsletter read by 64K+ readers!!- https://lnkd.in/d5UrNVtT image generated by DALL-E 3 #ainews #aihospital #aiagents #ainewsletter #aiupdates #aiinnovation #aidevelopments #aifuture #aiinhealthcare #healthcare
Larger spike-specific antibody and T cell responses in person vaccinated 217 times within 29 months against SARS-CoV-2, compared to 3-dose mRNA cohort. Read the full report below: #hypervaccination #covid19 #vaccination #vaccine
Heisenberg Professor for T Cell Immunology | Medical Specialist for Microbiology, Virology and Epidemiology of Infectious Diseases
Ever wondered what would happen if you get vaccinated against the same antigen over and over again? In "The Lancet Infectious Diseases", we now report on a hypervaccinated individual from Magdeburg (HIM) who received 217 vaccinations within 29 months against SARS-CoV-2. https://lnkd.in/dUkJXczE When, in 2022, the media reported about a man from Germany who received at least 90 vaccinations against SARS-CoV-2, we (as many others) wondered what kind of consequences such hypervaccination would have on the immune system. HIM underwent hypervaccination for private reasons outside of a clinical study context & against national vaccination recommendations. The public prosecutor of Magdeburg opened an investigation of HIM's case with the allegation of fraud, but criminal charges were not filed. In total, we have confirmation for 134 out of 217 vaccinations. HIM did not report any vaccination-related side effects. From 2019-2023, 62 routine clinical chemistry parameters showed no abnormalities attributable to hypervaccination. Notably, HIM had no signs of a past SARS-CoV-2 infection as indicated through various repeatedly neg. tests. Compared to 3-dose mRNA reference cohort, HIM's spike-specific antibody and T cell responses were larger in size without a strong positive or negative effect on the quality of the responses themselves. While HIM remains SARS-CoV-2 infection-free, any causal association cannot be made. It should go without saying that we do not endorse hypervaccination. Putative positive immunological effects cannot be justified by the number of medical interventions that each vaccination represents. Extreme settings like the one we report here are rare and therefore, almost inevitably, individual cases. The generalizability is thus, of course, unclear. However, we can still learn from such settings which consequences hyperimmunization can have on human immunity. This work was made possible only by a huge team effort at the FAU Erlangen-Nürnberg/Universitätsklinikum Erlangen. My sincere gratitude goes to leading authors Katharina Kocher, Carolin Moosman, Ev-Marie Schuster and the whole lab as well as all collaborators. We are also grateful, naturally, to HIMself, but also to Siegfried Krell (MVZ Medizinisches Labor Bremen GmbH) as well as the BMBF, the Deutsche Forschungsgemeinschaft (DFG) - German Research Foundation and the Else Kröner-Fresenius-Stiftung for supporting this work. Funders had no influence on the study design and data interpretation. 🙏 Here's the English press release...: https://lnkd.in/d6qwwfUG ...und hier ist die deutsche Pressemitteilung: https://lnkd.in/dtnG6HQT
